Evelo Biosciences, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Evelo Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Evelo Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $800K, unchanged year-over-year.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2022 was $3.1M, a 3.33% increase from 2021.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2021 was $3M, a 10% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $800K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $800K +$62K +8.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $738K -$99K -11.8% Jan 1, 2021 Mar 31, 2021 10-Q 2021-04-29
Q2 2020 $1.63M Apr 1, 2020 Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $837K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.